Table 1 Association between KLK5 mRNA expression levels and clinical characteristics in patients with advanced HGSOC stage FIGO III/IV
Clinical parameters | No. of patients | KLK5 |
|---|---|---|
Low/high a | ||
Age |  | p = 0.476 |
 ≤ 60 years | 58 | 35 (60%)/23 (40%) |
 > 60 years | 80 | 53 (66%)/27 (34%) |
Residual tumor mass |  | p = 0.041 |
 0 mm | 70 | 51 (73%)/19 (27%) |
 > 0 mm | 66 | 37 (56%)/29 (44%) |
Ascites fluid volume |  | p = 0.087 |
 ≤ 500 ml | 77 | 54 (70%)/23 (30%) |
 > 500 ml | 54 | 30 (56%)/24 (44%) |
FIGO stage |  | p = 0.051 |
 IIIA + IIIB | 15 | 13 (87%)/2 (13%) |
 IIIC + IV | 123 | 75 (61%)/48 (39%) |